Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on developing breakthrough treatments for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
16.22
+0.00 (+0.00%)
Range 16.09 - 16.36
Open 16.22
Prev Close 16.22
52 Week 7.65 - 16.36
Volume 447180
Market Cap 1.68B
*Delayed 7/27/2016 4:00 EDT

 
Form 8937 for 2015 Reverse Stock Split

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000